Envelope-chimeric Entry-targeted Measles Virus Escapes Neutralization and Achieves Oncolysis

Measles virus (MV) is a promising vector for cancer therapy and multivalent vaccination, but high prevalence of pre-existing neutralizing antibodies may reduce therapeutic efficacy, particularly following systemic administration. MV has only one serotype, but here we show that its envelope glycoprot...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Miest, Tanner S, Yaiw, Koon-Chu, Frenzke, Marie, Lampe, Johanna, Hudacek, Andrew W, Springfeld, Christoph, von Messling, Veronika, Ungerechts, Guy, Cattaneo, Roberto
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2011
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3188758/
https://ncbi.nlm.nih.gov/pubmed/21610701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2011.92
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares